Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02028 | Pages: 200 | Charts: 71 | Tables: 166 |
The global single-use bioprocessing market size was valued at $7.0 billion in 2020, and is projected to reach $38.8 billion by 2030, growing at a CAGR of 18.4% from 2021 to 2030.Single-use bioprocessing employs disposable technologies for the development and manufacturing of pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), personalized medicine, and others. The adoption of single-use bioprocessing products has witnessed significant increase during the developmental stages of drugs and manufacturing of several biopharmaceuticals. This product has revolutionized the upstream as well as downstream processes of manufacturing drugs making it faster, simpler, and cheaper. Factors that boost the growth of single-use bioprocessing market include surge in demand for biopharmaceuticals, rise in adoption of disposable technologies, low risk of product cross-contamination attributed to SUB technologies, and less floor space requirement. However, certain aspects such as extractability & leachability issues and stringent regulations pertaining to use of disposable systems in biopharmaceutical industry hamper the market growth.
The Single-use bioprocessing market size in this report is studied on the basis of product, application, method, end user, and region. On the basis of product, the market is divided by bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, media bags & containers, mixing systems, tubing assemblies, sampling systems, and others. By application, the market is divided into monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and others. By method, the market is classified into filtration, storage, cell culture, mixing, and purification. On the basis of end user, the market is divided into biopharmaceutical manufacturers, life science R&D companies & academic research institutes, and contract research organizations & manufacturers. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment review
By Product
On the basis of product, the media bags & containers segment currently dominates the global single-use bioprocessing market and is expected to continue this trend during the forecast period owing to single-use bioprocessing media bags & containers used in various bioprocessing processes. In addition, single-use containers are widely used for critical liquid handling applications in the bio manufacturing and biopharmaceutical industries. Moreover, single-use bioprocessing technologies are used in the production of monoclonal antibodies (mAb).
[PRODUCTGRAPH]
By Method
On the basis of method, the filtration segment dominated the global single-use bioprocessing market forecast in 2020 and is anticipated to be dominant in the market as it is a vital method to manufacture biological products such as vaccine, monoclonal antibodies, and others.
[METHODGRAPH]
By Application
On the basis of application, the monoclonal antibody production segment dominated the global single-use bioprocessing market in 2020 and is anticipated to be dominant in the market as monoclonal antibodies are immensely useful to treat various immune disorders and are an integral part of vaccine development.
[APPLICATIONGRAPH]
By End User
On the basis of end user, the biopharmaceutical manufacturers segment dominated the global single-use bioprocessing market forecast in 2020 and is anticipated to be dominant in the market owing to increased adoption of these systems for enhanced production of vaccines, monoclonal antibodies, and personalized medicines.
[ENDUSERGRAPH]
Region Segment Review
Region wise, North America single-use bioprocessing market growth dominated the market in 2020, as there is an on-going trend of introducing novel single-use bioprocessing devices in developed economies such as the U.S. and Canada, and then unveiling it to the rest of the world. North America is known for its healthcare facilities and medical services. In addition, rise in the adoption of single-use bioprocessing technologies for various biopharmaceutical applications has propelled the growth of the market. However, Asia-Pacific single-use bioprocessing industry is expected to witness considerable market growth during the forecast period due to significant demand for bioprocess equipment including laboratory filtration systems and membrane-based microbial analysis among many others. In addition, Asia-Pacific witnessed strong growth in both the pharma and laboratory equipment market, which is expected to offer lucrative opportunities for single-use bioprocessing products in future. Moreover, India and China is expected to grow at high CAGR in Asia-Pacific single-use bioprocessing market.
[REGIONGRAPH]
The major companies profiled in this report include 3M Company, Cesco Bioengineering Co. Ltd., Danaher Corporation, Eppendorf AG., Corning, Inc., Getinge Group, Merck KGaA, PBS Biotech, Sartorius Stedim Biotech, and Thermo Fisher Scientific, Inc.
Key Benefits For Stakeholders
Key Market Segments
Key Market Players